Twist Bioscience secures $50m to advance DNA Synthesis Platform
The synthetic DNA provider Twist Bioscience Corporation has completed a private placement of $50m to advance its proprietary, silicon-based DNA Synthesis Platform.
Archives for April 3, 2018
Smaller firms driving full-service CRO work as Big Pharma rethinks its outsourcing strategy
The CRO industry is expected to grow at a CAGR of 5-6% over the next 5 years, despite a move by Big Pharma to take more control of clinical trials, bringing work back in-house.
Bioavailability increasing nanoparticle tech receives US patent
Nanoparticle delivery technology that transports compounds to the bloodstream and cells can increase bioavailability and reduce adverse effects of cannabinoids and bioactive compounds, says NanoSphere Health Sciences.
Ongoing regulatory issues helps downgrade Wockhardt’s ratings
India Ratings has downgraded Wockhardt partly on the back of ongoing remediation at seven manufacturing facilities.